SUMMARY
Brokerage Radar: Goldman Sachs says 'buy' Ambuja Cements' shares whereas BofAML sees Axis Bank as a re-rating candidate. Meanwhile, Morgan Stanley believes that valuation of SBI Life Insurance Company is attractive at current levels. Here are top brokerage calls for this morning -

BofAML on Axis Bank | The brokerage firm sees room for further re-rating for Axis Bank on the basis of earnings consistency. The brokerage firm has maintained its 'buy' rating on shares of Axis Bank.

Morgan Stanley on SBI Life Insurance Company | Valuation of SBI Life Insurance Company appears attractive at current levels, said Morgan Stanley. The brokerage firm has maintained its 'overweight' rating on the insurance company's stock.

Credit Suisse on SBI Life | Valuation captures much of the underlying sentiment, said Credit Suisse has a 'neutral' call on SBI Life stock. The brokerage firm has cut EPS estimates for FY23 and FY24 by 2 percent owing to higher claims.

Goldman Sachs on Axis Bank | The company may grow its earnings at 29 percent compounded annually over FY22-25, according to Goldman Sachs. The brokerage firm has a 'buy' recommendation on the bank's stock.

Goldman Sachs on Ambuja Cements | The cement manufacturer may continue to narrow the profitability gap with industry leaders, as per Goldman Sachs. The brokerage firm says 'buy' the cement maker's shares.